On November 29, 2019, Marco Boorsma notified Milestone Pharmaceuticals Inc. (the “Company”) of his decision to resign from the Board of Directors of the Company (the “Board”), including any committees of the Board, effective November 29, 2019. Mr. Boorsma’s resignation from the Board is not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.